Drug Shortage Report for KALETRA
Report ID | 159917 |
Drug Identification Number | 02243644 |
Brand name | KALETRA |
Common or Proper name | Lopinavir/ritonavir oral solution |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | RITONAVIR LOPINAVIR |
Strength(s) | 100MG 400MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 160mL bottle |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-05-03 |
Actual start date | 2022-05-03 |
Estimated end date | 2022-06-02 |
Actual end date | 2022-05-25 |
Shortage status | Resolved |
Updated date | 2022-05-26 |
Company comments | As a result of an increase in demand, we are closely monitoring our inventory for Kaletra Oral Solution 80mg/20 mg, 160mL. KALETRA oral solution (80/20 mg/mL) continues to be available, however current stock available is short-dated, expiring June 1, 2022. KALETRA film-coated tablets (100/25mg) and KALETRA film-coated tablets (200/50 mg) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-05-26 | English | Compare |
v7 | 2022-05-25 | English | Compare |
v6 | 2022-05-25 | French | Compare |
v5 | 2022-05-25 | English | Compare |
v4 | 2022-05-04 | English | Compare |
v3 | 2022-05-03 | French | Compare |
v2 | 2022-05-03 | English | Compare |
v1 | 2022-05-03 | English | Compare |
Showing 1 to 8 of 8